| Literature DB >> 36208316 |
Kai Ueltzhöffer1,2, Corinna Roth1, Corinne Neukel1, Katja Bertsch1,3, Friederike Nüssel4, Sabine C Herpertz5.
Abstract
Protected moral values facilitate empathic concern for others, who are exposed to an existential threat, so that one spontaneously helps without taking into account utilitarian cost-benefit considerations. Subjects scoring high on the "Dark Triad" machiavellism, psychopathy, and narcissism are prone to ignore such appeals for selfless help. Until now, data on moral processing and moral decision-making following requests for altruistic help, which directly contrast appeals to protected and non-protected values in subjects with high and low scores on Dark Triad traits, have been missing. In this pilot study 25 healthy subjects with high and 27 with low Dark Triad scores participated in this functional magnetic resonance imaging study. We used a script-driven imagery paradigm to directly contrast requests for selfless help appealing to protected versus non-protected, negotiable moral values. Appeals to protected versus non-protected moral values elicited stronger activations in a large network including insula, amygdala, supramarginal gyrus, and dorsolateral prefrontal cortex. Non-protected values evoked stronger activation in superior frontal sulcus, occipito-temporal junction, and posterior cingulate cortex. During decision-making, high-scorers on the Dark Triad showed increased activations in the superior parietal lobule, precuneus, and intraparietal sulcus. Behaviorally, protected versus non-protected values strongly reduced the reliance on personal cost-benefit calculations in low-scorers, while high-scorers continued to rely on utilitarian deliberations. Data suggest that appeals to protected versus non-protected values activate distinct brain regions associated with strong moral emotions, other-directed cognition, and rule-based decision-making processes. High-scorers display an increased reliance on cost-benefit calculations, which persists even when protected values are threatened.Entities:
Keywords: Dark triad; Functional MRI; Moral values; Protected values; Script-based imagery
Year: 2022 PMID: 36208316 PMCID: PMC9547089 DOI: 10.1007/s00406-022-01489-3
Source DB: PubMed Journal: Eur Arch Psychiatry Clin Neurosci ISSN: 0940-1334 Impact factor: 5.760
Sample description
| Low-scorer ( | High-scorer ( | Group difference | ||||
|---|---|---|---|---|---|---|
| Mean | Std | Mean | Std | |||
| SD3 sum | 51.8 | 3.3 | 90.3 | 6.5 | − 27.1 | < 0.001* |
| SD3 psychopathy | 11.5 | 1.3 | 24.5 | 4.4 | − 14.5 | < 0.001* |
| SD3 narcissm | 21.8 | 3.5 | 33.0 | 4.6 | − 10.0 | < 0.001* |
| SD3 machiavellianism | 18.5 | 3.4 | 32.8 | 4.0 | − 13.9 | < 0.001* |
| 32.47 | 15.24 | 23.51 | 19.99 | 1.83 | 0.074 | |
| Educationc | 13.48 | 1.25 | 13.32 | 0.74 | 0.56 | 0.58 |
| Aged | 26.74 | 6.30 | 22.88 | 2.68 | 2.84 | 0.007* |
SD3 Short Dark Triad
aParticipants in the lowest vs. highest quartile of an initially recruited sample, with respect to their score in the “short Dark Triad” questionnaire
bCompetence score in the moral competence test
cYears of education
dIn years
p < 0.05
Fig. 1Schematic depiction of a single narrative. Each narrative consists of the following phases: (1) A phase outlining a neutral baseline situation (“baseline script phase”). (2) A set-up phase, outlining the context and the personal stakes of the participant in the following moral dilemma (“set-up script phase”). (3) A moral dilemma, in which the participant is appealed to help a second person, thereby incurring some cost by himself (e.g., a monetary cost, missing an important flight or appointment; “value script phase”). (4) The question, “How should I decide?”. (5) A decision and rating recording phase. Script phases are separated by an 8 s inter-phase interval, and successive scripts are separated by a 20 s inter-script interval
Multi-level linear regression models of behavioral data
| Decisiona | Changea | |||||
|---|---|---|---|---|---|---|
| Beta | 95% CIb | Beta | 95% CIb | |||
| Valued | 3.31 | (2.65; 20.70) | < 0.001* | − 3.23 | (− 6.03, − 2.56) | 0.001* |
| Groupe | − 0.77 | (− 2.10; 0.07) | 0.023* | 0.60 | (− 0.68, 2.29) | 0.206 |
| Value × group | − 0.40 | (− 16.93; 1.73) | 0.371 | 1.36 | (0.00; 3.83) | 0.006* |
| Age | − 0.13 | (− 0.80; 0.36) | 0.296 | 0.32 | (− 0.30, 1.08) | 0.127 |
aBivariate variables describing if subjects decided to help/if subjects would change their decision for any amount of money (1 = yes, 0 = no)
bConfidence interval between 2.5 and 97.5 percentiles, as determined by 10.000 bootstrapping iterations
cDetermined by 10.000 random permutations of group and value labels
dBivariate variable (1 = protected, 0 = nonprotected)
eBivariate variable (1 = high-scorer, 0 = low-scorer)
fRatings on a visual analog scale (0–100)
*Significant after correction for multiple comparisons using the Benjamini–Hochberg procedure with a false-discovery rate of 0.05
Fig. 2Marginal means for the probability of answering “yes” to the question “Would you change your decision for any amount of money?”, plotted for individual subjects (red: low-scorers, blue: high-scorers. Individual points were randomly jittered for better identifiability of individual subjects). Estimated marginal means and standard deviations from multi-level linear logistic regression model shown in black
Fig. 3Functional imaging results. Statistical contrast of the BOLD response during the value script phase in the total sample, when an appeal to A a protected versus a non-protected value is made, and B vice versa. C Statistical contrast of the BOLD response during the decision-making phase, in participants scoring high versus low on the short Dark Triad scale. D Beta values extracted from the peaks of the bilateral IPS clusters shown in C. rAMY right amygdala, ldlPFC left dorsolateral prefrontal cortex, rSMG right supramarginal gyrus, dPCC dorsal posterior cingulate cortex, vPCC ventral posterior cingulate cortex, IPS intraparietal sulcus. The statistical maps resulting from the 2nd level analyses were visualized using MRIcroGL (https://github.com/rordenlab/MRIcroGL12; (Rorden & Brett, 2000)), using the spm152 anatomical template